To learn more about how the delivery of medical information affects therapy choices for participants with advanced forms of cancer.
Primary Objectives • To examine how provision of medical information (risks, benefits, time toxicity, prognosis, oncologists' recommendation, and costs) affects preference for palliative systemic therapy in participants with advanced cancer. Secondary Objective • To examine how different options of medical information (risks/benefits, time toxicity, prognosis, oncologists' recommendation, and costs) affect preference for palliative systemic therapy in participants with advanced cancer. Exploratory Objective * To examine how the order of presentation of medical information affects preference for palliative systemic therapy in participants with advanced cancer. * To examine the association between intrinsic participants characteristics (such as participants demographics, symptoms, anxiety, depression, illness understanding, acceptance, coping strategies, religious coping, hope, decision making style, trust in oncologist, financial distress) and preference for palliative systemic therapy in participants with advanced cancer.
Study Type
OBSERVATIONAL
Enrollment
400
Particpants will complete about 16 questionnaires that will have questions about particpants quality of life, anxiety, health, andcase scenarios that are not real or based on particpants actual health situation.
MD Anderson Cancer Center
Houston, Texas, United States
RECRUITINGOverall Survival (OS)
Progression Free Survival (PFS)
Time frame: Through study completion; an average of 1 year.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.